Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

254

HTML

2227

Figures (1-4)

129

Tables (1-1)

126

Sum=2736

Mar 14, 2006 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 14, 2006; 12(10): 1621-1625
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1621

Full Size Figure Download Figure

Figure 3 Logistic regression analysis to determine the relationship between TI and anti-TI-ab in patients with IBD.

Citation: Sawada K, Takahashi R, Saniabadi AR, Ohdo M, Shimoyama T. Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. World J Gastroenterol 2006; 12(10): 1621-1625
URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1621.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i10.1621